FFF Enterprises: BioSupply Trends


	CDC Says Flu Trends Still Rising Flu activity in the United States continued its late-season rise last week, with more respiratory specimens testing positive and more states reporting widespread activity, but flu-like illness stayed relatively low overall, the US Centers for Disease Control and Prevention (CDC) said today. Read the full article » Military Advances Battle Against Flu U.S. drug-development company MediVector has been given a military contract to further develop a therapeutic against multiple influenza viruses. The broad-based therapeutic is Favipiravir (T-705). It could be effective against the 2009 H1N1 pandemic virus and drug-resistant influenza strains as well as common influenza. Read the full article » The Link Between PIDD and Skin Cancer People who have primary immune deficiency diseases (PIDDs) are susceptible to a number of life-threatening health complications. One that should not get overlooked is skin cancer. Read the full article » Read the full magazine »

Rates per gram are effective January 1, 2012 through March 31, 2012.

Product	Hospital Outpatient	Physician's Office

Carimune NF	60.48	61.64
Flebogamma 5% & 10% DIF	70.15*	70.15
Gammagard Liquid	74.43	75.86
Gammagard S/D	60.48	61.64
Gammaked	73.82	75.24
Gammaplex	74.59*	74.59
Gamunex-C	73.82	75.24
Octagam	111.60†	113.75‡
Privigen	68.81	70.13

*ASP + 6% (pass-through drug)
†WAC + 4% (based on Wholesale Acquisition Cost until ASP is re-established)
‡WAC + 6% (based on Wholesale Acquisition Cost until ASP is re-established)

From FDA
First Quadrivalent Influenza Vaccine Gains FDA Approval
more »

From Vaccine News Daily
Influenza Mechanism that Interferes with Antiviral Host Responses Found
more »

From Market Watch
Pfizer's Prevnar Meets Safety Goals in Child Study
more »

From CSL Behring
CSL Behring Recognized as a "Pioneer" by European Organization for Rare Diseases (EURORDIS)
more »